Helen Hobbs
Clinical Molecular Genetics · Dallas, TXNPI 1629177522
Payments from drug & device makers
$1,309,982in general payments, 2019–2025
Across 511 payments — averaging $2563.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1.3M
- E.r. Squibb & Sons, L.L.C.$4K
- Novo Nordisk$17
What the payments were for
- Consulting fees$1,138,38687%
- Travel & lodging$140,24711%
- Food & beverage$30,8342%
- Gifts$600%
- Entertainment$4560%
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 508 | $1,305,565 |
| E.r. Squibb & Sons, L.L.C. | 2 | $4,400 |
| Novo Nordisk | 1 | $17 |
How this compares
Too few clinical molecular genetics providers in Texasto place this figure against a meaningful peer group, so we don't.
Other clinical molecular genetics in Dallas
- Maria BlazoTemple$469
- Aslihan DincerAustin$117
- Emily WaskowSan Antonio$107
- Jianli DongGulveston$65
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.